This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2001 May-Jun;25(3):134-213.

doi: 10.1067/mcn.2001.116058.

The clinical pharmacology of the oral fluoropyrimidines

Affiliations

PMID: 11408845
DOI: 10.1067/mcn.2001.116058

Review

The clinical pharmacology of the oral fluoropyrimidines

C H Takimoto. Curr Probl Cancer. 2001 May-Jun.

. 2001 May-Jun;25(3):134-213.

doi: 10.1067/mcn.2001.116058.

Author

Affiliation

¹ Department of Medicine, Division of Medical Oncology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.

PMID: 11408845
DOI: 10.1067/mcn.2001.116058

No abstract available

PubMed Disclaimer

Similar articles

Oral fluoropyrimidines in colorectal cancer.
Van Cutsem E, Peeters M. Van Cutsem E, et al. Semin Oncol. 2000 Oct;27(5 Suppl 10):91-5. Semin Oncol. 2000. PMID: 11049039 Review. No abstract available.
[Oral fluoropyrimidines in oncology].
González Barón M. González Barón M. An R Acad Nac Med (Madr). 1998;115(3):721-45; discussion 745-6. An R Acad Nac Med (Madr). 1998. PMID: 10208021 Review. Spanish. No abstract available.
[5 -fluoropyrimidines for treatment of biliary tract cancers].
Morizane C, Okusaka T, Ueno H, Ikeda M. Morizane C, et al. Nihon Rinsho. 2006 Jan;64 Suppl 1:529-33. Nihon Rinsho. 2006. PMID: 16457319 Review. Japanese. No abstract available.
[Oral fluoropyrimidines in the treatment of colorectal carcinoma].
Porschen R. Porschen R. Dtsch Med Wochenschr. 2003 Jun 13;128 Suppl 2:S121-3. doi: 10.1055/s-2003-40145. Dtsch Med Wochenschr. 2003. PMID: 12817344 Review. German. No abstract available.
Oral fluoropyrimidine treatment of colorectal cancer.
Eng C, Kindler HL, Schilsky RL. Eng C, et al. Clin Colorectal Cancer. 2001 Aug;1(2):95-103. doi: 10.3816/CCC.2001.n.009. Clin Colorectal Cancer. 2001. PMID: 12445367 Review.

See all similar articles

Cited by

Comparison of 4 Screening Methods for Detecting Fluoropyrimidine Toxicity Risk: Identification of the Most Effective, Cost-Efficient Method to Save Lives.
Capitain O, Seegers V, Metges JP, Faroux R, Stampfli C, Ferec M, Budnik TM, Senellart H, Rossi V, Blouin N, Dauvé J, Campone M. Capitain O, et al. Dose Response. 2020 Sep 14;18(3):1559325820951367. doi: 10.1177/1559325820951367. eCollection 2020 Jul-Sep. Dose Response. 2020. PMID: 32973417 Free PMC article.
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients.
Del Re M, Cinieri S, Michelucci A, Salvadori S, Loupakis F, Schirripa M, Cremolini C, Crucitta S, Barbara C, Di Leo A, Latiano TP, Pietrantonio F, Di Donato S, Simi P, Passardi A, De Braud F, Altavilla G, Zamagni C, Bordonaro R, Butera A, Maiello E, Pinto C, Falcone A, Mazzotti V, Morganti R, Danesi R. Del Re M, et al. Pharmacogenomics J. 2019 Dec;19(6):556-563. doi: 10.1038/s41397-019-0077-1. Epub 2019 Feb 6. Pharmacogenomics J. 2019. PMID: 30723313 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science